...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Cancer Commences Operations !!!??

IMO it's a bad idea to post your thoughts in fake news releases like that. Yes I know it's an obvious fantasy fake (assuming everybody reads your first line and catches the future date).

Share
New Message
Please login to post a reply